All PlansAdministrativeMedium impact
07.07.09j, Stem-Cell Therapy/Platelet-Rich Plasma for Orthopedic Applications and Platelet-Rich Plasma/Platelet-Derived Growth Factor for Wound Healing and Other Miscellaneous Non-Orthopedic Conditions
Independence Blue Cross·Medical Policy
We identified it
Jun 25, 2026
Summary
Failed to analyze policy change